Frontlight ResearchEarly access
Trial site
Izmir Ekonomi Universitesi Medical Point Hastanesi
- 10running trials
- 1closed trial
The trials here
What the 11 trials at this site are about, from their registry records.
- Conditions
- Lung cancer7 trials
- Acute lymphoblastic leukaemia1 trial
- Bladder cancer1 trial
- Childhood cancers1 trial
- Colorectal cancer1 trial
- Ovarian cancer1 trial
- Pancreatic cancer1 trial
- Prostate cancer1 trial
- Phase
- Phase 37 trials
- Phase 11 trial
- Phase 1/21 trial
- Phase 21 trial
- Phase 2/31 trial
- Status
- Active, not recruiting5 trials
- Recruiting4 trials
- Completed1 trial
- Not yet recruiting1 trial
- Lead sponsor
- Amgen8 trials
- Mirati Therapeutics Inc.1 trial
- Seagen, a wholly owned subsidiary of Pfizer1 trial
- Taiho Oncology, Inc.1 trial
Running trials
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Study Comparing Tarlatamab With Standard of Care Chemotherapy in Relapsed Small Cell Lung Cancer
Recruiting
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
Active, not recruiting
A Study of Subcutaneous Blinatumomab Administration in Participants With R/R and MRD+ B-ALL
Recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer4 recruiting
- Bladder cancer1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 14 Nov 2026